Brief: Personalis Advances Business Strategy With Investment From Merck And Extends Collaboration With Moderna
Dec 19 (Reuters) - Merck & Co Inc MRK.N :
* PERSONALIS ADVANCES BUSINESS STRATEGY WITH INVESTMENT FROM
MERCK
AND EXTENDS COLLABORATION WITH MODERNA
* MERCK HAS AGREED TO PURCHASE $50 MILLION OF PERSONALIS
COMMON
STOCK IN A PRIVATE PLACEMENT AT A PRICE OF $3.56 PER SHARE
* MERCK TO OWN 16.5% OF PERSONALIS AFTER CLOSING
Source text: ID:nBw2BnlJ8a
Further company coverage: MRK.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Personalis
See all newsBrief: Personalis - Announces Commercial Launch Of Real-Time Variant Tracker In Next Personal Mrd Test
U.S. STOCKS ON THE MOVE-Becton Dickinson, Constellation Energy, Marvell
Personalis slips as BTIG downgrades, sees no rival bid for Tempus deal
Brief: Personalis Receives New Task Order Under U.S. Veterans Affairs Contract For VA MVP
Personalis, Inc. reports results for the quarter ended June 30 - Earnings Summary